Topchoice Medical Co., Inc. (SHSE:600763) commences a share repurchases on April 17, 2024, under the program mandated by the shareholders in the Extraordinary General Meeting held on April 17, 2024. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be purchased at a price not exceeding CNY 103.56 per share.

The repurchased shares will be used to reduce the company's registered capital. The repurchase will be funded from company's own or self-raised funds. The program will be valid for 12 months.